The Anaphylaxis Campaign is a founding member of the International Food Allergy & Anaphylaxis Alliance (IFAAA) representing 20 countries.  The IFAAA is an alliance of patient education groups from around the world. The Alliance’s mission is to unite organisations working

Following our Extraordinary General Meeting held yesterday in London – we are very proud to announce that from today, 24th September 2015, the Anaphylaxis Campaign is to merge with the Latex Allergy Support Group (LASG). Lynne Regent, CEO the Anaphylaxis

10/11/2015 The Health Conditions in Schools Alliance (HCSA) has gone live with a new website to help schools find information and advice on caring for children with health conditions quicker and easier than ever before. There are certain policies and

10/11/2015 The Anaphylaxis Campaign welcomes news that the Royal College of Physicians will host the first UK accreditation scheme for adult allergy services The Royal College of Physicians (RCP) Accreditation Unit will host the first clinical service accreditation scheme for

11/02/2013 The European Academy of Allergy and Clinical Immunology (EAACI) has said it will push for stricter EU legislation on allergen labelling, saying that current laws on ‘may contain’ labelling are insufficient to protect those with food allergies. The Anaphylaxis

18/02/2013 In light of the recent horse meat scandal, whereby various processed meat products from multiple companies have been found to contain up to 100% horse meat instead of the advertised beef mince, we were contacted by a number of

20/07/2015 An estimated 21 million adults in the United Kingdom currently suffer from an allergy (Mintel, 2010); this is over 20% of the UK population and is one of the highest prevalence rates in the world (Levy et al., 2004).

The Anaphylaxis Campaign participated in a groundbreaking meeting organised by the European Branch of the International Life Sciences Institute (ILSI-Europe) held on 13th and 14th September 2012. The workshop, entitled “Food Allergy: From Thresholds to Action Levels”, drew together key

Professor Gideon Lack, Dept of Paediartric Allergy, Kings College London, talks about the findings of the LEAP study.